Adverse Drug Reaction Reports of Patients and Healthcare Professionals: How Different Are They?

    Research output: Contribution to conferenceAbstractAcademic

    Abstract

    Background: Changes in the European pharmacovigilance
    legislation make it possible for patients of all
    European member states to report concerns regarding
    drugs directly to the national reporting centre for
    adverse drug reactions (ADRs). Despite a number of
    studies that have been conducted on patients as reporters
    in pharmacovigilance, typical characteristics of
    patients’ ADR reports compared to those of healthcare
    professionals (HCPs) are unclear.

    Objectives: To explore the differences in reported information
    between patients’ and HCPs’ ADR reports.
    Methods: A retrospective study among 200 anonymised
    patients’ and HCPs’ ADR reports. Reports were
    rendered anonymous and rated using a list of objective
    (for example start date of the ADR) and subjective
    (for example the impact of the ADR) elements of information that could be important considering ADR
    reporting. A two-side Pearson’s Chi-square test
    (p < 0.05) was used to detect statistically significant
    differences in the number of reported elements of
    information.

    Results: The reported information between patients’
    and HCPs’ reports is broadly consistent. However, differences
    were found in both objective and subjective
    elements of information; HCPs had a higher score for
    objective and patients for subjective elements. Elements
    of information that were more often reported
    by patients: outcome ADR, detailed description,
    course of ADR, impact the ADR on the patient’s daily
    of life, severity, patient’s weight and height, patient’s
    thoughts about causality, and contact with or between
    HCPs. Elements of information that were more often
    reported by HCPs: seriousness, registration number
    for drugs, dosage, route of administration, pharmaceutical
    form, other suspect drugs, medical history, and
    diagnosis confirmed with test results.

    Conclusions: Although the reported information is generally
    comparable, patients’ reports are more focused
    on the impact of the reported ADRs, whereas reports
    from HCPs provide more diagnosis related information.
    Original languageEnglish
    Publication statusPublished - 2013
    EventInternational Conference on Pharmacoepidemiology & Therapeutic Risk Management - , Canada
    Duration: 25-Aug-201328-Aug-2013

    Conference

    ConferenceInternational Conference on Pharmacoepidemiology & Therapeutic Risk Management
    Country/TerritoryCanada
    Period25/08/201328/08/2013

    Fingerprint

    Dive into the research topics of 'Adverse Drug Reaction Reports of Patients and Healthcare Professionals: How Different Are They?'. Together they form a unique fingerprint.

    Cite this